Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome HIDS: results from an open-label studyReport as inadecuate




Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome HIDS: results from an open-label study - Download this document for free, or read online. Document in PDF available to download.

Pediatric Rheumatology

, 13:O58

First Online: 28 September 2015 Download fulltext PDF



Author: JI Aróstegui - J Anton - I Calvo - A Robles - A Speziale - Y Joubert - G Junge - J Yagüe

Source: https://link.springer.com/







Related documents